PARASITE

Parasite Prevention-Cure with natural low cost high efficiency IUI Individual Universal Immunotherapy C-Life-IUI-CBM-SAV-SAS-SAT.

In-vivo/ex-vivo immune-regeneration system can eliminate/reverse harmful agents, including living organisms, pathogens like parasites, virus, fungus, bacteria, non-living threats as toxins and the effects of trauma or aging. Specialized antibodies and immune cells can eliminate and weaken parasites.

Parasites like Protozoa/Malaria generate Life abandonments of more than 600k/year, Schistozomose 200k and Ascaris Lumbricoides/ascariasis/round worms over 60k. Helminthiasis is an infestation of parasitic worms in human body, nematodes/roundworms, cestodes/tapeworms or trematodes/flukes.

Parasites, viruses, bacteria, fungi and other pathogens can attack the human body. These parasites include Protozoa and Helminths. Protozoa, single-celled organisms, cause diseases such as malaria, caused by Plasmodium and amoebiasis, caused by Entamoeba Histolytica.

Helminths are parasitic worms, including roundworms, tapeworms, flukes, that can cause diseases like schistosomiasis, caused by Schistosoma and ascariasis caused by Ascaris Lumbricoides. They can be eliminated in-vivo by antibodies/immune cells, such as IgE/Eosinophils, also supplemented ex-vivo.

MALARIA, Plasmodium Falciparum, protozoan parasite responsible for the most severe form, has a life cycle with different sizes. Sporozoites, the infectious form is injected by mosquitoes, 10-15/1 micro-meters length/diameter. Inside human body, grow/multiply in liver and produce merozoites 1.5/1mi-m.

Immune cells as macrophages/neutrophils engulf/destroy Plasmodium with phagocytosis. Antibodies as IgE can bind to the parasite, marking it for destruction by immune cells. Cytokine signaling molecules help also activate immune cells that kill the parasite.

C-Life Cubic Cell Culture Life

C-Life can combine CBM, Cell Bank Medculture and IUI, Individual Universal Immunotherapy to create ex-vivo supplementation to the similar in-vivo process, but in a reduced space/time to increase efficiency and to eliminate harmful agent including parasites, adding efficient quantities/types.

IUI Individual Universal Immunotherapy

Immune cells are extracted from the patient and exposed to antigens or a small load of pathogens in a controlled environment outside the body. This process helps train immune cells to recognize and attack the pathogen, determining quantity/type that is most effective.

These trained immune cells are then activated and expanded in number to ensure a robust response when reintroduced into the body. The activated and expanded immune cells are infused back into the patient. These cells/antibodies are now better quantified/equipped to recognize/combat the pathogen.

In-vivo immune and regeneration system can eliminate parasites efficiently, given average space/time quantity/quality of antibodies/immune cells/stromal-stem cells versus pathogens/parasites, circumstantial to +95% efficiency. Under 5% may need complement of ex-vivo similar system.

The immune system produces several substances/proteins/cells to combat macro parasites, such as helminths parasitic worms, as Immunoglobulin E. IgE antibodies bind to the surface of the parasite and mark it for destruction by immune cells such as Eosinophils, Mast Cells and Basophils.

Granulocyte Eosinophils, white blood cells, are activated by IgE and release toxic granules that can damage or kill parasites. Mast Cells/Basophils also bind to IgE, release histamine/other chemicals that contribute to inflammation and help expel the parasite from the body.

Cytokines, signaling molecules, such as interleukins, IL-4, IL-5, IL-13, play a crucial role in coordinating the immune response against parasites. These substances and immune cells work together to identify, attack and eliminate macro parasites from the body.

Protective capsules/pills of IgE antibodies and Eosinophils could reach the intestines
via mouth, rectum suppository/catheter, vascular system via nano-intra-skin patch, sub-lingual pill, nasal spray for IgE antibodies or micro-intra venal for granulocyte Eosinophils, to attack parasites.

Malaria Plasmodium Falciparum developed strategies to evade the human immune system in-vivo, that can be countered ex-vivo to accelerate in-vivo response, as antigenic variation where the parasite changes proteins on its surface. Ex-vivo antigens/antibodies/cells can help recognize/target them.

After infecting red blood cells, Malaria Plasmodium parasite can hide inside them, shielding itself from direct attack by immune cells. But ex-vivo immune system can supplement red cells, cytokines, antibodies and immune cells, trained to identify intra/extra cell parasite phases.

Infected red blood cells can stick to uninfected ones and to walls of blood vessels, preventing their clearance by the Spleen, a key organ in filtering out infected cells. Ex-vivo immune system can supplement red cells, cytokines, antibodies, immune cells, trained to identify intra/extra cell parasites.

Inhibition of apoptosis by Malaria Plasmodium can prevent the programmed cell death of infected liver cells, allowing it to survive and multiply within the host. But ex-vivo immune system can supplement red cells, cytokines, antibodies and immune cells, trained to identify intra/extra cell parasite phases.

Natural individual antigens, antibodies, antigen loaded adaptive immune cells, innate immune cells can be prepared ex vivo, exposing them to an inferior load of pathogens, to then be re-introduced in-vivo to overwhelm the pathogens with a pre-tested efficient strategy in terms of quantity and quality/type.

CBM Cell Bank Medculture

Cultivating cells/proteins ex-vivo, replicating the in-vivo defense process, can increase efficiency against parasites, being more efficient than traditional artificial allopathic treatments that also have collateral effects. Biologic Medicine of Permanent Life is based on natural technology paradigm.

SAV Super Auto Vaccine

Malaria current vaccines target specific proteins on the parasite surface. Empirical efficacy and real world effectiveness/efficiency is proportional to the dosage/load of antigen/adjuvant leading to a proportional/higher immune response. Quantity, quality/type and coverage determine +80% efficiency.

Current malaria vaccines target the CircumSporozoite Protein (CSP) on the surface of the Plasmodium falciparum sporozoites, stimulating the immune system to produce antibodies that block the sporozoites from infecting liver cells. Immune cells help destroy infected liver cells.

SAS Super Auto Supplement

In addition to supplementing antibodies and antigen loaded immune cells, nano mRNAs intra-skin and micro/macro molecules/proteins/cells intra-venal can replicate proven in-vivo processes ex-vivo, to raise efficiency in eliminating parasites, avoiding low efficiency, collateral effect artificial treatments.

SAT Super Auto Test

Mescope, microfluid saliva, blood, urine, mucus, sweat, tear and fecal matter can identify parasites, proteins/antigens via photonic imaging of cell phone, accessory lenses and network HAI, Human Artificial Intelligent enlargement/analysis, complemented by mini testing in mini-laboratory.